SCHEMBL10087685

SCHEMBL10087685

COc1ccccc1-c1noc(C)c1C(=O)N1CCN(c2cc(NC(=O)c3ccc(N4CCCC4)cc3)c([NH+]([O-])O)cc2Cl)CC1

nearest known ligand 0.55

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
TSHR P16473 5/20 0.55
MAPK1 P28482 1/20 0.55
LMNA P02545 4/20 0.49
HTT P42858 1/20 0.49
SMN1; SMN2 Q16637 2/20 0.48
ALDH1A1 P00352 5/20 0.48
KDM4E B2RXH2 3/20 0.46
GAA P10253 2/20 0.46
KMT2A Q03164 2/20 0.46
MEN1 O00255 1/20 0.46
TP53 P04637 1/20 0.45
TDP1 Q9NUW8 1/20 0.43
L3MBTL1 Q9Y468 1/20 0.43
EPAS1 Q99814 1/20 0.42
NPSR1 Q6W5P4 3/20 0.42
MAPT P10636 3/20 0.42
HSD17B10 Q99714 2/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16374952 0.89 TSHR (0.51) TSHRMAPK1LMNAHTTSMN1; SMN2
SCHEMBL470462 0.89 TSHR (0.53) TSHRMAPK1LMNAHTTSMN1; SMN2
SCHEMBL457864 0.88 TSHR (0.55) TSHRMAPK1LMNAHTTSMN1; SMN2
SCHEMBL470180 0.83 TSHR (0.48) TSHRMAPK1LMNAHTTSMN1; SMN2
SCHEMBL463035 0.81 TSHR (0.57) TSHRMAPK1LMNAHTTSMN1; SMN2
SCHEMBL457357 0.80 TSHR (0.53) TSHRMAPK1LMNAHTTSMN1; SMN2
SCHEMBL470304 0.80 TSHR (0.51) TSHRMAPK1LMNAHTTSMN1; SMN2
SCHEMBL12457262 0.80 TSHR (0.54) TSHRMAPK1LMNAHTTSMN1; SMN2
SCHEMBL470469 0.80 TSHR (0.52) TSHRMAPK1LMNAHTTSMN1; SMN2
SCHEMBL12457267 0.79 TSHR (0.51) TSHRMAPK1LMNAHTTSMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2012033736-A1 NOVEL PIPERAZINE ANALOGS AS BROAD-SPECTRUM INFLUENZA ANTIVIRALS BRISTOL-MYERS SQUIBB COMPANY (US) 2012-03-15 WO disclosed